1. Kaempferide Protects against Myocardial Ischemia/Reperfusion Injury through Activation of the PI3K/Akt/GSK-3β Pathway
   Dong Wang et al, 2017, Mediators of Inflammation CrossRef
2. Cost-Effectiveness of Evolocumab Therapy for Myocardial Infarction: The Chinese Healthcare Perspective
   Zhe Liang et al, 2021, Cardiovascular Drugs and Therapy CrossRef
3. Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury
   Duomao Lin et al, 2015, PLOS ONE CrossRef
4. Prognostic significance of whole blood viscosity estimated by de Simone’s formula in ST-elevation myocardial infarction
   Elif Hande Ozcan Cetin et al, 2016, Biomarkers in Medicine CrossRef
5. Tonifying Qi and activating blood circulation in terms of Traditional Chinese Medicine: their effects in patients with myocardial infarction
   Gao Wulin et al, 2018, Journal of Traditional Chinese Medicine CrossRef
6. Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
   Zhe Liang et al, 2021, Frontiers in Pharmacology CrossRef
7. Anagrelide alleviates myocardial ischaemia–reperfusion injury by inhibiting reticulated platelets
   Peng Zhang et al, 2023, Medical Hypotheses CrossRef
8. The low expression of miR-155 promotes the expression of SHP2 by inhibiting the activation of the ERK1/2 pathway and improves cell pyroptosis induced by I/R in mice
   Mengru Liu et al, 2024, Aging CrossRef
9. Esculetin inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury
   Ya He et al, 2018, Biochemical and Biophysical Research Communications CrossRef
10. Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults
    Yuliang Xiang et al, 2023, International Journal of Technology Assessment in Health Care CrossRef